Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-22

FDA Approved: REPAGLINIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Macleods Pharmaceuticals Limited's original Abbreviated New Drug Application for repaglinide, a meglitinide used to improve glycemic control in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repaglinide (Repaglinide)

Snippet

ORIG AP for REPAGLINIDE (REPAGLINIDE)